Free access
Gem
20 February 2015

Influenza Virus Reservoirs and Intermediate Hosts: Dogs, Horses, and New Possibilities for Influenza Virus Exposure of Humans

ABSTRACT

Influenza A virus (IAV) infections in hosts outside the main aquatic bird reservoirs occur periodically. Although most such cross-species transmission events result in limited onward transmission in the new host, sustained influenza outbreaks have occurred in poultry and in a number of mammalian species, including humans, pigs, horses, seals, and mink. Recently, two distinct strains of IAV have emerged in domestic dogs, with each circulating widely for several years. Here, we briefly outline what is known about the role of intermediate hosts in influenza emergence, summarize our knowledge of the new canine influenza viruses (CIVs) and how they provide key new information on the process of host adaptation, and assess the risk these viruses pose to human populations.

INTRODUCTION

Avian influenza viruses (IAVs) frequently spill over from their reservoirs in aquatic birds and infect humans but are generally poorly transmissible (13). It is often thought that the infection and transmission of avian influenza viruses among nonhuman mammals, particularly swine, facilitate their subsequent transfer to humans in a form that can be readily transmitted (2, 47), although evidence for such “intermediate” mammalian hosts in the emergence of human influenza viruses is limited. Among the few clearly documented examples is the 2009 H1N1 pandemic virus, for which there is strong evidence that it emerged in humans following the transfer of a swine influenza virus, itself comprised of gene segments of swine, human, and avian origin (8, 9). In addition, human viruses can frequently “spill back” to pigs (10, 11), suggesting that they comprise a single virus gene pool. Indeed, anthropozoonotic infections are far more common in pigs than are human infections with swine influenza viruses (12). The emergence of the H1N1 influenza virus in 1918 involved parallel epidemics of the virus in humans and swine, although it is unclear whether the virus emerged in humans and then spread to swine or the reverse (13). Similarly, although reassortment between avian and human viruses resulted in the emergence of the pandemic H2N2 virus (with new hemagglutinin [HA], neuraminidase [NA], and PB1 gene segments) and H3N2 virus (with new HA and PB1 gene segments) in 1957 and 1968, respectively, conclusive evidence of involvement of swine or another mammalian intermediate is lacking.
Only a small number of mammalian hosts are currently recognized as sustaining IAV transmission (Fig. 1), and it is not clear what distinguishes these species from those for which influenza has not been reported. Influenza viruses appear to be relatively host specific in mammals. A variety of barriers to virus infection are known, including innate immune responses and sialic acid receptors as well as a number of intracellular factors, and some viral mutations that overcome these barriers to facilitate replication and spread in new hosts have also been identified (14). Establishment of IAVs in new hosts is also dependent on the structure of the host population, which must be sufficiently large and interconnected to allow the sustained spread of the virus. In the last few centuries, the human population has increased significantly in size and connectivity, as have those of domestic food animals such as poultry, swine, and cattle in intensive agriculture, companion animals (cats and dogs) in households or in kennels or shelters, and some small animals raised in large numbers for fur or meat (1517). Bats may also be present in large, interconnected populations and appear to maintain their own IAVs, although these are phylogenetically distinct and have not been detected so far in other mammals, such that they are not an important reservoir (18, 19).
FIG 1
FIG 1 Schematic showing the known emergence events of influenza A viruses in mammals that led to extended outbreaks, including epidemics and pandemics. The diagram indicates the known mammalian hosts (humans, swine, seals, mink, horses, and dogs), as well the approximate periods during which those were known to sustain natural transmission in that host. The viruses are all assumed to have emerged from avian reservoirs to infect the initial mammalian hosts. The three known transfers between different mammalian hosts that went on to establish epidemics in the new hosts are indicated by red lines, and the first mammalian host therefore acted as the intermediate reservoir host for the transferred virus. The direction of transfer of the 1918 H1N1 virus is not known for certain, but the virus is now thought to have transferred from humans to swine, rather than the other way around. The transfers of new AIV gene segments into the human virus lineage are shown by the vertical arrows, and the segments are listed; these are assumed to involve a direct transfer of the gene segments from the avian ancestor in humans. There have been complex mixtures and transfers of genome segments among some of the viruses in swine, but most of those are not shown because they have not involved transfer between different hosts.

The emergence of CIVs.

The inventory of mammalian hosts that are known to sustain transmission of IAVs has increased in the past 15 years due to the emergence of two strains of the virus in dogs: the H3N8 equine influenza virus (EIV) that transferred to dogs in the United States in about 1999 and the avian virus-like H3N2 strain that transferred to dogs in Asia around 2005 or 2006. Both of these canine influenza viruses (CIVs) have continuously circulated in the dog population since they emerged, creating many opportunities for exposure in humans and other species.

Equine and canine H3N8 influenza viruses.

Horses have been natural hosts for sustained influenza transmission on at least three occasions, with an outbreak of an unknown equine influenza virus (EIV) subtype occurring in 1872 (20), an H7N7 EIV that emerged around 1956 (21), and an H3N8 EIV that was recognized around 1963 when there was an outbreak of respiratory disease in Florida that occurred soon after the importation of horses from Argentina (22). The H3N8 EIV appears to have emerged from an avian influenza virus that spread to horses, and there was some reassortment of that virus with the H7N7 viruses in the 1960s and 1970s that eventually died out during the 1970s (23). Limited transmission of H3N8 EIV to dogs, including in the United Kingdom (2002) (24) and Australia (2007) (25), has been observed on a number of independent occasions. However, despite these spillover events, only one EIV transfer that occurred around 1999 in the United States resulted in the establishment of H3N8 canine influenza virus in dogs in Florida, which involved the transmission of a single EIV strain from horses. This outbreak was first described in 2004 as the cause of disease among racing greyhounds, and the virus was transferred within a year to racing tracks in many parts of the United States (26) and, subsequently, to other dog populations and breeds where it has been maintained ever since (27, 28). Notably, H3N8 CIV appears to have been primarily maintained since about 2008 in animal shelters in a few large cities where dogs live in dense populations and where susceptible animals are introduced at high rates (27, 29, 30). Because infected dogs are frequently transferred from these shelters, the virus is often passed to other dog populations where it causes outbreaks but where it is seemingly unable to sustain long-term transmission, likely because of overly heterogeneous contact networks (27, 29). In particular, although there are an estimated 80 million susceptible household dogs in the United States, they appear to lack the degree of contact necessary for continuous transmission of influenza virus such that chains of transmissions quickly die out (29). As a result, CIV infections in small shelters or in the household dog populations die out within days or weeks (27, 29). To date, no reassortment by the H3N8 CIV with any other human or animal influenza viruses has been detected.
It is therefore clear that horses acted as an intermediate host for the emergence of the canine H3N8 strain, although only after about 37 years of continuous circulation of the virus, suggesting that there are major adaptive or epidemiological barriers to CIV emergence. Since its emergence, the H3N8 CIV lineage has diverged from the EIVs that have continued to circulate in horses, with distinct amino acid substitutions in each gene segment, some of which may have been selected for canine adaptation (30, 31). For example, certain amino acid substitutions in the sialic acid binding site modify the replication of the virus in the respiratory tract of the dog by altering the binding to the sulfated glycans and likely by other changes to sialic acid binding (32). Those EIV strains that circulated at the time of emergence of CIV appear to readily infect dogs after experimental challenge or under conditions in which dogs are housed with EIV-infected horses (33, 34) and can infect canine tracheal explant cultures (35), so the amount of adaptation required to infect dogs with these viruses is likely small. Notably, there is currently no evidence for transfer of a CIV back to horses in nature, and CIV replicates inefficiently when used to challenge horses or horse tracheal cells (3638). Besides the infection in dogs, the H3N8 influenza virus has also been reported to infect pigs in China (39) and to infect cats in experimental studies (40).

H3N2 canine influenza virus.

The H3N2 CIV most likely arose around 2005 or 2006 in China but was first recognized in South Korea around the same time, and the virus or specific antibodies have since been detected in many parts of China and Korea, as well as Thailand (4144). The epidemiology of the H3N2 CIV is still poorly understood, but some reports indicate moderate seroprevalence in some household dog populations, and it has been transferred over long distances both within and between the three countries in which has been detected (45). Populations of farmed dogs may play a role in the maintenance of the virus (46). H3N2 CIV is an avian virus-like strain, and all isolates share a single common ancestor, but the circumstances of the transfer are unknown, and its gene segments are related to both Eurasian and American avian influenza virus lineages (42, 47). H3N2 CIV appears to have a relatively broad host range, and the virus naturally infects cats and spreads among them under some circumstances (48). Under experimental conditions, H3N2 CIV has also been shown to infect ferrets, albeit with limited transmission (49, 50).
Despite its recent emergence, reassortants between H3N2 CIV and other influenza viruses, including a CIV carrying the M segment of human influenza virus H1N1, have been described (51). Another CIV has been suggested to harbor the nucleoprotein (NP) segment of an avian influenza virus related to H5N1 viruses (46), although that is not a clear reassortant (P. R. Murcia, unpublished results). Notably, an H3N1 influenza virus carrying the H3 of CIV and the other gene segments from the H1N1 pandemic human influenza virus has also been reported (52). This should be a cause of concern, as previous influenza pandemics have originated when viruses harboring a novel HA were introduced into the human population.

Intermediate hosts and CIV spread to other species (including humans)?

There are only a small number of well-documented examples of mammalian intermediate hosts allowing virus transfer onward to new hosts or acting as “mixing vessels” facilitating reassortment leading to new outbreaks. In addition to transmission of the human H1N1 pandemic virus and the likely role of humans in the emergence of the classical H1N1 virus in swine in 1918, horses clearly played a role in the emergence of the H3N8 virus in dogs. The CIV/human virus reassortant reported for the H3N2 CIV means that we should be alert to the possible emergence of intact or reassortant CIVs in humans. Such a threat results from the extensive and sustained contacts between humans and their pet dogs, which would result in significant human exposure to CIV if the viruses were to spread widely among household dogs. It is also possible that additional reassortments between canine and human viruses could occur in dogs or humans or possibly other hosts such as cats, potentially creating a new human influenza virus for which there may be little or no natural immunity. Clearly, these risks may vary depending on the virus, with H3N2 CIV seemingly posing a greater risk that H3N8 CIV (see below). Importantly, to date there have been no documented transmissions of H3N8 EIV or CIV to humans despite the close interactions between humans and horses since the first appearance of EIV in the early 1960s or between humans and dogs since 2000 (53, 54). However, direct experimental inoculation of human volunteers with EIV in the 1960s showed that infection did occur but only at low levels (55). These results suggest that there are high intrinsic barriers to the establishment of H3N8 in humans, such that onward transmission in two mammalian hosts (horses and dogs) does not guarantee successful infection of another (humans).
In contrast, the observation of H3N2 CIV-human virus reassortants in dogs shows that coinfection of one of the hosts (likely dogs) is possible and hence a cause for concern. In addition, H3N8 EIV has been isolated from pigs in Asia (39) and from bactrian camels in Mongolia (56), and swine are susceptible to infection with many avian virus-like and human virus strains (10, 11). However, the ability of canine influenza viruses to infect pigs (and the ability of pig influenza viruses to infect dogs) has not been formally tested.

Control strategies and CIV eradication.

Despite the emergence and spread of the CIVs in both the United States and Asia, there may still be opportunities to control or even eradicate the viruses while they are in their reservoir hosts. Although the household dog population in the United States is about a quarter the size of the human population, the transmission of influenza virus among dogs appears to be much less efficient than that of influenza viruses among humans (27, 29). After 14 years of continuous dog-to-dog transmission, H3N8 CIV is still circulating in a sustained fashion only among dogs in a small number of large animal shelters, and the transmission rate is sufficiently low that the virus might be eradicated from those shelters by reducing the rate of transmission or by reducing the efficiency of infection (29). The spread of the H3N2 CIV in Asia may likewise also be controlled by timely interventions, particularly if the household dog population is similarly inefficient in allowing virus transmission, so that the virus is being maintained in other dog-rearing or -housing facilities.

Concluding remarks.

The emergence of canine influenza viruses, like the emergence of any influenza virus lineage in a novel mammalian host population, may constitute a direct or indirect pandemic risk. However, adaptation to mammals should not be seen as a direct conduit to emergence in humans. Clearly, there are important host barriers that have yet to be understood or breached. While the lack of transmission of EIV or CIV to humans suggests that long-standing infection of a mammal does not necessarily indicate a threat to humans, a better understanding of the ecological, evolutionary, and molecular mechanisms of influenza emergence is essential to accurately determine which viruses pose a risk to human health.

ACKNOWLEDGMENTS

C.R.P. and E.C.H. were supported by grant R01 GM080533 from the National Institutes of Health. P.R.M. is supported by the Medical Research Council of the United Kingdom. E.C.H. is supported by an NHMRC Australia Fellowship (AF30).

REFERENCES

1.
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179.
2.
Webster RG, Govorkova EA. 2014. Continuing challenges in influenza. Ann N Y Acad Sci 1323:115–139.
3.
Reperant LA, Kuiken T, Osterhaus AD. 2012. Influenza viruses: from birds to humans. Hum Vaccin Immunother 8:7–16.
4.
Scholtissek C, Naylor E. 1988. Fish farming and influenza pandemics. Nature 331:215.
5.
Webby RJ, Webster RG. 2001. Emergence of influenza A viruses. Philos Trans R Soc Lond B Biol Sci 356:1817–1828.
6.
Ma W, Kahn RE, Richt JA. 2008. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J Mol Genet Med 3:158–166.
7.
Khiabanian H, Trifonov V, Rabadan R. 2009. Reassortment patterns in Swine influenza viruses. PLoS Curr 1:RRN1008.
8.
Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125.
9.
Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201.
10.
Crisci E, Mussá T, Fraile L, Montoya M. 2013. Review: influenza virus in pigs. Mol Immunol 55:200–211.
11.
Ma W, Lager KM, Vincent AL, Janke BH, Gramer MR, Richt JA. 2009. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 56:326–337.
12.
Nelson MI, Wentworth DE, Culhane MR, Vincent AL, Viboud C, LaPointe MP, Lin X, Holmes EC, Detmer SE. 2014. Introductions and evolution of human-origin seasonal influenza a viruses in multinational swine populations. J Virol 88:10110–10119.
13.
Worobey M, Han GZ, Rambaut A. 2014. Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci U S A 111:8107–8112.
14.
Cauldwell AV, Long JS, Moncorge O, Barclay WS. 2014. Viral determinants of influenza A virus host range. J Gen Virol 95:1193–1210.
15.
Gortazar C, Reperant LA, Kuiken T, de la Fuente J, Boadella M, Martinez-Lopez B, Ruiz-Fons F, Estrada-Pena A, Drosten C, Medley G, Ostfeld R, Peterson T, VerCauteren KC, Menge C, Artois M, Schultsz C, Delahay R, Serra-Cobo J, Poulin R, Keck F, Aguirre AA, Henttonen H, Dobson AP, Kutz S, Lubroth J, Mysterud A. 2014. Crossing the interspecies barrier: opening the door to zoonotic pathogens. PLoS Pathog 10:e1004129.
16.
Reperant LA, Rimmelzwaan GF, Kuiken T. 2009. Avian influenza viruses in mammals. Rev Sci Tech 28:137–159.
17.
Matrosovich M, Stech J, Klenk HD. 2009. Influenza receptors, polymerase and host range. Rev Sci Tech 28:203–217.
18.
Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO. 2012. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109:4269–4274.
19.
Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. 2014. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22:183–191.
20.
Coady JH. 1977. The 1872 epizootic. J Amer Vet Med Assoc 170:668.
21.
Sovinova O, Tumova B, Pouska F, Nemec J. 1958. Isolation of a virus causing respiratory disease in horses. Acta Virol 2:52–61.
22.
Waddell GH, Teigland MB, Sigel MM. 1963. A new influenza virus associated with equine respiratory disease. J Am Vet Med Assoc 143:587–590.
23.
Murcia PR, Wood JL, Holmes EC. 2011. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol 85:5312–5322.
24.
Daly JM, Blunden AS, Macrae S, Miller J, Bowman SJ, Kolodziejek J, Nowotny N, Smith KC. 2008. Transmission of equine influenza virus to English foxhounds. Emerg Infect Dis 14:461–464.
25.
Crispe E, Finlaison DS, Hurt AC, Kirkland PD. 2011. Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak. Aust Vet J 89(Suppl 1):27–28.
26.
Crawford PC, Dubovi EJ, Castleman WL, Stephenson I, Gibbs EP, Chen L, Smith C, Hill RC, Ferro P, Pompey J, Bright RA, Medina MJ, Johnson CM, Olsen CW, Cox NJ, Klimov AI, Katz JM, Donis RO. 2005. Transmission of equine influenza virus to dogs. Science 310:482–485.
27.
Pecoraro HL, Bennett S, Huyvaert KP, Spindel ME, Landolt GA. 2014. Epidemiology and ecology of H3N8 canine influenza viruses in US shelter dogs. J Vet Intern Med 28:311–318.
28.
Anderson TC, Crawford PC, Dubovi EJ, Gibbs EP, Hernandez JA. 2013. Prevalence of and exposure factors for seropositivity to H3N8 canine influenza virus in dogs with influenza-like illness in the United States. J Am Vet Med Assoc 242:209–216.
29.
Dalziel BD, Huang K, Geoghegan JL, Arinaminpathy N, Dubovi EJ, Grenfell BT, Ellner SP, Holmes EC, Parrish CR. 2014. Contact heterogeneity, rather than transmission efficiency, limits the emergence and spread of canine influenza virus. PLoS Pathog 10:e1004455.
30.
Hayward JJ, Dubovi EJ, Scarlett JM, Janeczko S, Holmes EC, Parrish CR. 2010. Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J Virol 84:12636–12645.
31.
Rivailler P, Perry IA, Jang Y, Davis CT, Chen LM, Dubovi EJ, Donis RO. 2010. Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008. Virology 408:71–79.
32.
Collins PJ, Vachieri SG, Haire LF, Ogrodowicz RW, Martin SR, Walker PA, Xiong X, Gamblin SJ, Skehel JJ. 2014. Recent evolution of equine influenza and the origin of canine influenza. Proc Natl Acad Sci U S A 111:11175–11180.
33.
Yamanaka T, Nemoto M, Tsujimura K, Kondo T, Matsumura T. 2009. Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet Microbiol 139:351–355.
34.
Pecoraro HL, Bennett S, Garretson K, Quintana AM, Lunn KF, Landolt GA. 2013. Comparison of the infectivity and transmission of contemporary canine and equine H3N8 influenza viruses in dogs. Vet Med Int 2013:874521.
35.
Gonzalez G, Marshall JF, Morrell J, Robb D, McCauley JW, Perez DR, Parrish CR, Murcia PR. 2014. Infection and pathogenesis of canine, equine and human influenza viruses in canine tracheas. J Virol 88:9208–9219.
36.
Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Muranaka M, Ueno T, Kinoshita Y, Niwa H, Hidari KI, Suzuki T. 2012. No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8). Acta Vet Scand 54:25.
37.
Yamanaka T, Tsujimura K, Kondo T, Matsumura T, Ishida H, Kiso M, Hidari KI, Suzuki T. 2010. Infectivity and pathogenicity of canine H3N8 influenza A virus in horses. Influenza Other Respir Viruses 4:345–351.
38.
Quintana AM, Hussey SB, Burr EC, Pecoraro HL, Annis KM, Rao S, Landolt GA. 2011. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells. Am J Vet Res 72:1071–1078.
39.
Tu J, Zhou H, Jiang T, Li C, Zhang A, Guo X, Zou W, Chen H, Jin M. 2009. Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China. Arch Virol 154:887–890.
40.
Su S, Wang L, Fu X, He S, Hong M, Zhou P, Lai A, Gray G, Li S. 2014. Equine influenza A(H3N8) virus infection in cats. Emerg Infect Dis 20:2096–2099.
41.
Song D, Kang B, Lee C, Jung K, Ha G, Kang D, Park S, Park B, Oh J. 2008. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis 14:741–746.
42.
Bunpapong N, Nonthabenjawan N, Chaiwong S, Tangwangvivat R, Boonyapisitsopa S, Jairak W, Tuanudom R, Prakairungnamthip D, Suradhat S, Thanawongnuwech R, Amonsin A. 2014. Genetic characterization of canine influenza A virus (H3N2) in Thailand. Virus Genes 48:56–63.
43.
Wang H, Jia K, Qi W, Zhang M, Sun L, Liang H, Du G, Tan L, Shao Z, Ye J, Sun L, Cao Z, Chen Y, Zhou P, Su S, Li S. 2013. Genetic characterization of avian-origin H3N2 canine influenza viruses isolated from Guangdong during 2006–2012. Virus Genes 46:558–562.
44.
Lee YN, Lee DH, Lee HJ, Park JK, Yuk SS, Sung HJ, Park HM, Lee JB, Park SY, Choi IS, Song CS. 2012. Serologic evidence of H3N2 canine influenza virus infection before 2007. Vet Rec 171:477.
45.
Yang X, Liu C, Liu F, Liu D, Chen Y, Zhang H, Qu L, Li Y, Xia D, Liu M. 2014. Identification and genetic characterization of avian-origin H3N2 canine influenza viruses isolated from the Liaoning province of China in 2012. Virus Genes 49:342–347.
46.
Su S, Cao N, Chen J, Zhao F, Li H, Zhao M, Wang Y, Huang Z, Yuan L, Wang H, Zhang G, Li S. 2012. Complete genome sequence of an avian-origin H3N2 canine influenza A virus isolated in farmed dogs in southern China. J Virol 86:10238.
47.
Park SJ, Moon HJ, Kang BK, Hong M, Na W, Kim JK, Poo H, Park BK, Song DS. 2012. Complete genome sequence of an avian-origin H3N2 canine influenza virus isolated from dogs in South Korea. J Virol 86:9548–9549.
48.
Jeoung HY, Lim SI, Shin BH, Lim JA, Song JY, Song DS, Kang BK, Moon HJ, An DJ. 2013. A novel canine influenza H3N2 virus isolated from cats in an animal shelter. Vet Microbiol 165:281–286.
49.
Lee YN, Lee DH, Park JK, Yuk SS, Kwon JH, Nahm SS, Lee JB, Park SY, Choi IS, Song CS. 2013. Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2). J Gen Virol 94(Pt 2):293–297.
50.
Kim H, Song D, Moon H, Yeom M, Park S, Hong M, Na W, Webby RJ, Webster RG, Park B, Kim JK, Kang B. 2013. Inter- and intraspecies transmission of canine influenza virus (H3N2) in dogs, cats, and ferrets. Influenza Other Respir Viruses 7:265–270.
51.
Moon H, Hong M, Kim JK, Seon B, Na W, Park SJ, An DJ, Jeoung HY, Kim DJ, Kim JM, Kim SH, Webby RJ, Webster RG, Kang BK, Song D. 30 June 2014, posting date. H3N2 canine influenza virus with the matrix gene from the pandemic A/H1N1 virus: infection dynamics in dogs and ferrets. Epidemiol Infect.
52.
Song D, Moon HJ, An DJ, Jeoung HY, Kim H, Yeom MJ, Hong M, Nam JH, Park SJ, Park BK, Oh JS, Song M, Webster RG, Kim JK, Kang BK. 2012. A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea. J Gen Virol 93:551–554.
53.
Khurelbaatar N, Krueger WS, Heil GL, Darmaa B, Ulziimaa D, Tserennorov D, Baterdene A, Anderson BD, Gray GC. 2014. Little evidence of avian or equine influenza virus infection among a cohort of Mongolian adults with animal exposures, 2010–2011. PLoS One 9:e85616.
54.
Burnell FJ, Holmes MA, Roiko AH, Lowe JB, Heil GL, White SK, Gray GC. 2014. Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia. J Clin Virol 59:100–103.
55.
Kasel JA, Alford RH, Knight V, Waddell GH, Sigel MM. 1965. Experimental infection of human volunteers with equine influenza virus. Nature 206:41–43.
56.
Yondon M, Zayat B, Nelson MI, Heil GL, Anderson BD, Halpin RA, McKenzie PP, White SK, Wentworth DE, Gray G. 2014. Equine influenza A (H3N8) virus isolated from a bactrian camel, Mongolia. Emerg Infect Dis 20:2144–2147.

Information & Contributors

Information

Published In

cover image Journal of Virology
Journal of Virology
Volume 89Number 615 March 2015
Pages: 2990 - 2994
Editor: S. Schultz-Cherry
PubMed: 25540375

History

Published online: 20 February 2015

Permissions

Request permissions for this article.

Contributors

Authors

Colin R. Parrish
Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA
Pablo R. Murcia
Medical Research Council—University of Glasgow Centre for Virus Research, Institute of Infection, Inflammation and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
Edward C. Holmes
Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, School of Biological Sciences and Sydney Medical School, University of Sydney, Sydney, NSW, Australia

Editor

S. Schultz-Cherry
Editor

Notes

Address correspondence to Colin R. Parrish, [email protected].

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy